Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company that develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products. Its portfolio includes BAQSIMI, a dry nasal spray for emergency treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for temporary relief of mild intermittent asthma symptoms; Glucagon for injection emergency kit; Enoxaparin, an injectable low molecular weight heparin for prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. It also offers Cortrosyn as a diagnostic agent for adrenocortical insufficiency, Amphadase (bovine-sourced hyaluronidase injection), Epinephrine injection for allergic reactions, Lidocaine products for anesthesia, Phytonadione injection (vitamin K1) for newborns, emergency syringe products (atropine, calcium chloride, dextrose, epinephrine, lidocaine, sodium bicarbonate), Albuterol sulfate inhalation aerosol for bronchospasm, Iron sucrose injection for iron deficiency anemia in chronic kidney disease, Teriparatide injection for osteoporosis, and Ipratropium Br.

Amphastar Pharmaceuticals, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol AMPH. Its shares are traded in US Dollars (USD). The company is headquartered in the United States and its primary listing is on a major US exchange, making it accessible to investors in the US and globally.

Amphastar Pharmaceuticals operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. This means the company focuses on producing both generic versions of existing drugs and specialty pharmaceuticals, often targeting specific therapeutic areas. Its products include injectables, inhalations, and intranasal formulations, covering a range of conditions from diabetes and asthma to opioid overdose and diagnostic testing.

Amphastar Pharmaceuticals markets its products in the United States, China, and France. While the company is based in the US, it has an international presence, particularly in China and France, indicating a strategy to expand its reach beyond its home market. The company's products are developed and manufactured with a focus on these regions, though its primary market remains the United States.

Amphastar's portfolio includes several notable products across different therapeutic areas. BAQSIMI is a dry nasal spray for severe hypoglycemia emergencies. Primatene MIST provides temporary relief for mild intermittent asthma. Enoxaparin is used for deep vein thrombosis prevention and treatment. REXTOVY and Naloxone address opioid overdose. Cortrosyn is a diagnostic agent for adrenocortical insufficiency. Amphadase is a hyaluronidase injection. The company also offers emergency syringe products (atropine, calcium chloride, dextrose, epinephrine, lidocaine, sodium bicarbonate), Albuterol sulfate for bronchospasm, Iron sucrose for anemia in chronic kidney disease, and Teriparatide for osteoporosis.